These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 14717967)

  • 1. Enhanced leukocyte-platelet cross-talk in Type 1 diabetes mellitus: relationship to microangiopathy.
    Hu H; Li N; Yngen M; Ostenson CG; Wallén NH; Hjemdahl P
    J Thromb Haemost; 2004 Jan; 2(1):58-64. PubMed ID: 14717967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of insulin on platelet and leukocyte activity in whole blood.
    Hu H; Hjemdahl P; Li N
    Thromb Res; 2002 Sep; 107(5):209-15. PubMed ID: 12479880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast medium attenuates platelet activation and platelet-leukocyte cross-talk.
    Ji Q; Ghaly M; Hjemdahl P; Tornvall P; Li N
    Thromb Haemost; 2005 May; 93(5):922-6. PubMed ID: 15886810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-leukocyte cross talk in whole blood.
    Li N; Hu H; Lindqvist M; Wikström-Jonsson E; Goodall AH; Hjemdahl P
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2702-8. PubMed ID: 11116075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise-induced platelet and leucocyte activation is not enhanced in well-controlled Type 1 diabetes, despite increased activity at rest.
    Hu H; Johansson BL; Hjemdahl P; Li N
    Diabetologia; 2004 May; 47(5):853-9. PubMed ID: 15095037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced P-selectin expression and increased soluble CD40 Ligand in patients with Type 1 diabetes mellitus and microangiopathy: evidence for platelet hyperactivity and chronic inflammation.
    Yngen M; Östenson CG; Hu H; Li N; Hjemdahl P; Wallén NH
    Diabetologia; 2004 Mar; 47(3):537-540. PubMed ID: 14963650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for prothrombotic effects of exercise and limited protection by aspirin.
    Li N; Wallén NH; Hjemdahl P
    Circulation; 1999 Sep; 100(13):1374-9. PubMed ID: 10500036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lipid-lowering treatment on platelet reactivity and platelet-leukocyte aggregation in diabetic patients without and with chronic kidney disease: a randomized trial.
    Almquist T; Jacobson SH; Lins PE; Farndale RW; Hjemdahl P
    Nephrol Dial Transplant; 2012 Sep; 27(9):3540-6. PubMed ID: 22700717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The possible association of in vivo leukocyte-platelet heterophilic aggregate formation and the development of diabetic angiopathy.
    Kaplar M; Kappelmayer J; Veszpremi A; Szabo K; Udvardy M
    Platelets; 2001 Nov; 12(7):419-22. PubMed ID: 11674859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin, but not proinsulin C-peptide, enhances platelet fibrinogen binding in vitro in Type 1 diabetes mellitus patients and healthy subjects.
    Hu H; Li N; Ekberg K; Johansson BL; Hjemdahl P
    Thromb Res; 2002 Apr; 106(2):91-5. PubMed ID: 12182905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephropathy in type 1 diabetes is associated with increased circulating activated platelets and platelet hyperreactivity.
    Tarnow I; Michelson AD; Barnard MR; Frelinger AL; Aasted B; Jensen BR; Parving HH; Rossing P; Tarnow L
    Platelets; 2009 Nov; 20(7):513-9. PubMed ID: 19852691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus.
    Demirtunc R; Duman D; Basar M; Bilgi M; Teomete M; Garip T
    J Diabetes Complications; 2009; 23(2):89-94. PubMed ID: 18358749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-leukocyte aggregation under shear stress: differential involvement of selectins and integrins.
    Hu H; Varon D; Hjemdahl P; Savion N; Schulman S; Li N
    Thromb Haemost; 2003 Oct; 90(4):679-87. PubMed ID: 14515189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Spontaneous' platelet aggregation in whole blood in diabetic patients with and without microvascular disease.
    Hendra TJ; Yudkin JS
    Diabet Med; 1992 Apr; 9(3):247-51. PubMed ID: 1576806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin treatment does not attenuate platelet or leukocyte activation as monitored by whole blood flow cytometry.
    Li N; Hu H; Hjemdahl P
    Thromb Res; 2003; 111(3):165-70. PubMed ID: 14678815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-leukocyte-cross-talk in diabetes mellitus.
    Tschoepe D; Rauch U; Schwippert B
    Horm Metab Res; 1997 Dec; 29(12):631-5. PubMed ID: 9497901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocytes can enhance platelet-mediated aggregation and thromboxane release via interaction of P-selectin glycoprotein ligand 1 with P-selectin.
    Faraday N; Scharpf RB; Dodd-o JM; Martinez EA; Rosenfeld BA; Dorman T
    Anesthesiology; 2001 Jan; 94(1):145-51. PubMed ID: 11135734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis.
    Ogura H; Kawasaki T; Tanaka H; Koh T; Tanaka R; Ozeki Y; Hosotsubo H; Kuwagata Y; Shimazu T; Sugimoto H
    J Trauma; 2001 May; 50(5):801-9. PubMed ID: 11371835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet aggregation and coagulation factors in insulin dependent diabetics with and without microangiopathy.
    Dallinger KJ; Jennings PE; Toop MJ; Gyde OH; Barnett AH
    Diabet Med; 1987; 4(1):44-8. PubMed ID: 2951219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus.
    Fasching P; Veitl M; Rohac M; Streli C; Schneider B; Waldhäusl W; Wagner OF
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4313-7. PubMed ID: 8954033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.